FDA Inspection 946968 — Avadel Legacy Pharmaceuticals LLC

Avadel Legacy Pharmaceuticals LLC — FEI 3008832322

The FDA completed an inspection of Avadel Legacy Pharmaceuticals LLC on September 23, 2015 in Chesterfield, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 23, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chesterfield, MO (United States)

Citations

IDCFRDescription
891121 CFR 314.81(b)(1)(ii)Failure to meet specifications